A Phase I Study to Assess the Safety and Cancer‐Homing Ability of Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells in Men with Localized Prostate Cancer - Schweizer, Michael T.; Wang, Hao; Bivalacqua, Trinity J.; Partin, Alan W.; Lim, Su Jin; Chapman, Carolyn; Abdallah, Rehab; Levy, Oren; Bhowmick, Neil A.; Karp, Jeffrey M.; De Marzo, Angelo; Isaacs, John T.; et al. (Stem cells translational medicine, 2019)
Keywords: Adolescent; Adult; Androgens; Animal models; Animals; Antibiotics; Bone marrow; Cancer; Cancer surgery; Cancer therapies; Cellular therapy; Cell‐Based Drug Development, Screening, and Toxicology; Chemotaxis; Clinical trials; Cytotoxic agents; Cytotoxicity; Deoxyribonucleic acid; DNA; Drug dosages; Humans; Intravenous administration; Laboratories; Male; Mesenchymal Stem Cell Transplantation - methods; Mesenchymal stem cells; Mesenchymal Stem Cells - metabolism; Mesenchyme; Metastases; Metastasis; Middle Aged; Oncology, Experimental; Penicillin; Polymerase chain reaction; Prostate cancer; Prostatectomy; Prostatic Neoplasms - physiopathology; Quality of Life - psychology; Stem cell transplantation; Stem cells; Transplantation, Homologous - methods; Tumors; West Nile virus; Young Adult; Clinical trials; Chemotaxis; Cellular therapy; Mesenchymal stem cells